| Literature DB >> 34166334 |
Lauren B Zapata, Karen Pazol, Kathryn M Curtis, Debra J Kane, Tara C Jatlaoui, Suzanne G Folger, Ekwutosi M Okoroh, Shanna Cox, Maura K Whiteman.
Abstract
Ensuring access to contraceptive services is an important strategy for preventing unintended pregnancies, which account for nearly one half of all U.S. pregnancies (1) and are associated with adverse maternal and infant health outcomes (2). Equitable, person-centered contraceptive access is also important to ensure reproductive autonomy (3). Behavioral Risk Factor Surveillance System (BRFSS) data collected during 2017-2019 were used to estimate the proportion of women aged 18-49 years who were at risk for unintended pregnancy* and had ongoing or potential need for contraceptive services.† During 2017-2019, in the 45 jurisdictions§ from which data were collected, 76.2% of women aged 18-49 years were considered to be at risk for unintended pregnancy, ranging from 67.0% (Alaska) to 84.6% (Georgia); 60.7% of women had ongoing or potential need for contraceptive services, ranging from 45.3% (Puerto Rico) to 73.7% (New York). For all jurisdictions combined, the proportion of women who were at risk for unintended pregnancy and had ongoing or potential need for contraceptive services varied significantly by age group, race/ethnicity, and urban-rural status. Among women with ongoing or potential need for contraceptive services, 15.2% used a long-acting reversible method (intrauterine device or contraceptive implant), 25.0% used a short-acting reversible method (injectable, pill, transdermal patch, or vaginal ring), and 29.5% used a barrier or other reversible method (diaphragm, condom, withdrawal, cervical cap, sponge, spermicide, fertility-awareness-based method, or emergency contraception). In addition, 30.3% of women with ongoing or potential need were not using any method of contraception. Data in this report can be used to help guide jurisdictional planning to deliver contraceptive services, reduce unintended pregnancies, ensure that the contraceptive needs of women and their partners are met, and evaluate efforts to increase access to contraception.Entities:
Mesh:
Year: 2021 PMID: 34166334 PMCID: PMC8224864 DOI: 10.15585/mmwr.mm7025a2
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586
Estimated numbers and percentages of women aged 18–49 years who were at risk for unintended pregnancy* and had ongoing or potential need for contraceptive services, by jurisdiction — Behavioral Risk Factor Surveillance System, 45 jurisdictions, 2017–2019
| Jurisdiction | Women aged 18–49 yrs | |||
|---|---|---|---|---|
| Total no.¶ | % at risk for unintended pregnancy (95% CI) | No. and % who had ongoing or potential need for contraceptive services | ||
| No. (95% CI)¶ | % (95% CI) | |||
| Alabama | 1,005,000 | 76.8 (73.5–79.8) | 571,800 (533,700–610,000) | 56.9 (53.1–60.7) |
| Alaska | 146,300 | 67.0 (60.6–72.9) | 75,600 (65,400–85,700) | 51.7 (44.7–58.6) |
| Arizona | 1,444,100 | 80.9 (76.6–84.5) | 875,100 (804,400–943,000) | 60.6 (55.7–65.3) |
| Arkansas | 596,100 | 75.3 (70.5–79.5) | 347,500 (316,500–377,900) | 58.3 (53.1–63.4) |
| California | 8,514,600 | 70.6 (67.6–73.5) | 5,091,700 (4,810,700–5,355,700) | 59.8 (56.5–62.9) |
| Connecticut | 694,700 | 82.7 (79.6–85.3) | 481,400 (455,700–505,000) | 69.3 (65.6–72.7) |
| Delaware | 189,900 | 79.6 (74.0–84.3) | 125,300 (114,100–135,800) | 66.0 (60.1–71.5) |
| District of Columbia | 192,700 | 73.9 (69.5–78.0) | 131,600 (122,700–139,900) | 68.3 (63.7–72.6) |
| Florida | 4,130,200 | 80.4 (76.4–83.9) | 2,589,600 (2,403,800–2,767,200) | 62.7 (58.2–67.0) |
| Georgia | 2,226,700 | 84.6 (81.0–87.6) | 1,572,100 (1,474,100–1,661,100) | 70.6 (66.2–74.6) |
| Hawaii | 275,300 | 70.8 (67.5–73.8) | 164,400 (154,400–174,000) | 59.7 (56.1–63.2) |
| Idaho | 350,100 | 77.9 (73.7–81.7) | 188,000 (170,100–205,500) | 53.7 (48.6–58.7) |
| Illinois | 2,604,400 | 78.6 (75.1–81.7) | 1,669,400 (1,567,800–1,763,200) | 64.1 (60.2–67.7) |
| Indiana | 1,349,100 | 75.7 (72.6–78.6) | 785,200 (739,300–831,000) | 58.2 (54.8–61.6) |
| Iowa | 613,400 | 79.4 (77.0–81.6) | 348,400 (330,600–365,600) | 56.8 (53.9–59.6) |
| Kansas | 573,400 | 77.6 (74.9–80.0) | 342,900 (325,700–358,900) | 59.8 (56.8–62.6) |
| Louisiana | 968,400 | 79.8 (76.3–82.9) | 625,600 (586,900–662,400) | 64.6 (60.6–68.4) |
| Maine | 244,500 | 71.5 (66.8–75.8) | 131,300 (118,800–143,800) | 53.7 (48.6–58.8) |
| Maryland | 1,214,500 | 77.0 (74.2–79.5) | 763,900 (727,500–800,400) | 62.9 (59.9–65.9) |
| Massachusetts | 1,420,600 | 80.1 (76.9–83.0) | 964,600 (913,400–1,012,900) | 67.9 (64.3–71.3) |
| Minnesota | 1,119,500 | 78.9 (76.9–80.8) | 690,700 (665,000–715,400) | 61.7 (59.4–63.9) |
| Mississippi | 610,100 | 75.4 (71.7–78.8) | 338,600 (313,600–362,400) | 55.5 (51.4–59.4) |
| Missouri | 1,222,900 | 78.9 (75.4–82.0) | 694,600 (644,500–743,500) | 56.8 (52.7–60.8) |
| Montana | 203,400 | 80.6 (77.4–83.4) | 115,900 (108,200–123,500) | 57.0 (53.2–60.7) |
| Nebraska | 380,800 | 80.1 (76.9–83.0) | 243,300 (229,200–256,700) | 63.9 (60.2–67.4) |
| Nevada | 619,000 | 73.7 (68.2–78.6) | 359,000 (322,500–394,300) | 58.0 (52.1–63.7) |
| New Jersey | 1,792,400 | 74.9 (71.4–78.1) | 1,100,500 (1,032,400–1,166,900) | 61.4 (57.6–65.1) |
| New Mexico | 409,000 | 81.0 (77.2–84.3) | 246,600 (228,200–264,200) | 60.3 (55.8–64.6) |
| New York | 4,069,700 | 81.6 (77.1–85.4) | 2,999,400 (2,800,000–3,178,400) | 73.7 (68.8–78.1) |
| North Carolina | 2,155,000 | 71.3 (67.1–75.2) | 1,204,600 (1,109,800–1,299,500) | 55.9 (51.5–60.3) |
| Ohio | 2,281,900 | 78.1 (74.0–81.8) | 1,360,000 (1,255,000–1,460,400) | 59.6 (55.0–64.0) |
| Oklahoma | 788,500 | 75.6 (70.5–80.0) | 414,000 (371,400–455,000) | 52.5 (47.1–57.7) |
| Oregon | 861,400 | 82.0 (78.8–84.8) | 528,900 (495,300–560,800) | 61.4 (57.5–65.1) |
| Pennsylvania | 2,446,600 | 77.7 (73.9–81.1) | 1,460,600 (1,357,900–1,560,900) | 59.7 (55.5–63.8) |
| Rhode Island | 215,300 | 80.3 (75.4–84.5) | 144,700 (133,500–155,200) | 67.2 (62.0–72.1) |
| South Carolina | 1,010,300 | 79.3 (75.8–82.4) | 640,500 (599,100–678,900) | 63.4 (59.3–67.2) |
| South Dakota | 170,200 | 81.4 (76.4–85.5) | 103,100 (92,900–112,700) | 60.6 (54.6–66.2) |
| Tennessee | 1,362,800 | 78.4 (74.2–82.0) | 800,000 (735,900–861,300) | 58.7 (54.0–63.2) |
| Texas | 6,093,500 | 67.4 (63.1–71.5) | 3,199,100 (2,918,800–3,479,400) | 52.5 (47.9–57.1) |
| Utah | 707,100 | 75.4 (73.2–77.6) | 403,000 (386,100–420,700) | 57.0 (54.6–59.5) |
| Virginia | 1,759,700 | 78.9 (75.7–81.7) | 1,113,900 (1,050,500–1,173,700) | 63.3 (59.7–66.7) |
| West Virginia | 333,400 | 76.7 (72.6–80.3) | 170,400 (154,700–185,700) | 51.1 (46.4–55.7) |
| Wisconsin | 1,125,000 | 79.5 (74.8–83.4) | 717,800 (661,500–770,600) | 63.8 (58.8–68.5) |
| Wyoming | 111,500 | 78.5 (74.0–82.4) | 63,300 (57,300–69,100) | 56.8 (51.4–62.0) |
| Puerto Rico | 734,000 | 75.6 (72.7–78.2) | 332,500 (309,700–356,000) | 45.3 (42.2–48.5) |
|
|
|
|
|
|
Abbreviation: CI = confidence interval.
* Women were considered to be at risk for unintended pregnancy unless they reported 1) not being sexually active with a male partner, 2) being currently pregnant or seeking pregnancy, 3) not minding being pregnant, or 4) having had a hysterectomy.
† Women with ongoing or potential need for contraceptive services were defined as women considered to be at risk for unintended pregnancy not using permanent contraception (female sterilization or male partner vasectomy). The number of women with ongoing or potential need for contraceptive services can be used to estimate how many women might seek services.
§ Data shown are from 2019, except 2017 data are shown for seven jurisdictions: Alaska, California, District of Columbia, Maine, Nevada, New Jersey, and Texas.
¶ Weighted numbers are rounded to the nearest 100.
Estimated numbers and percentages of women aged 18–49 years who were at risk for unintended pregnancy* and had ongoing or potential need for contraceptive services, by selected sociodemographic characteristics — Behavioral Risk Factor Surveillance System, 45 jurisdictions, 2017–2019
| Sociodemographic characteristic | Women aged 18–49 yrs | |||
|---|---|---|---|---|
| Total no.¶ | % at risk for unintended pregnancy (95% CI) | No. and % who had ongoing or potential need for contraceptive services | ||
| No. (95% CI)¶ | % (95% CI) | |||
|
| ||||
| 18–24 | 13,992,200 | 71.5 (69.5–73.5)** | 9,696,600 (9,402,800–9,990,400) | 69.3 (67.2–71.4)** |
| 25–34 | 20,042,800 | 74.5 (73.0–75.9) | 12,867,500 (12,546,800–13,188,200) | 64.2 (62.6–65.8) |
| 35–44 | 18,901,000 | 79.5 (78.1–80.8) | 10,263,200 (9,960,800–10,546,800) | 54.3 (52.7–55.8) |
| 45–49 | 8,401,100 | 80.4 (78.6–82.1) | 4,435,800 (4,251,000–4,620,600 | 52.8 (50.6–55.0) |
|
| ||||
| White, non-Hispanic | 30,888,700 | 78.0 (77.0–78.9)** | 18,131,700 (17,791,900–18,471,400) | 58.7 (57.6–59.8)** |
| Black, non-Hispanic | 8,764,100 | 75.3 (73.1–77.5) | 5,723,000 (5,503,900–5,933,300) | 65.3 (62.8–67.7) |
| Hispanic | 14,526,100 | 75.5 (73.6–77.2) | 8,948,100 (8,643,000–9,238,600) | 61.6 (59.5–63.6) |
| Other | 6,305,400 | 70.8 (67.1–74.2) | 3,903,000 (3,657,100–4,136,300) | 61.9 (58.0–65.6) |
|
| ||||
| Yes | 51,112,100 | 76.2 (75.3–77.1) | 30,871,700 (30,360,600–31,382,800) | 60.4 (59.4–61.4) |
| No | 9,915,300 | 76.8 (74.7–78.8) | 6,167,300 (5,929,300–6,395,400) | 62.2 (59.8–64.5) |
|
| ||||
| Yes | 43,835,000 | 76.7 (75.7–77.6) | 26,651,700 (26,213,300–27,133,900) | 60.8 (59.8–61.9) |
| No | 16,704,300 | 75.3 (73.6–76.9) | 10,056,000 (9,755,300–10,356,700) | 60.2 (58.4–62.0) |
|
| ||||
| Urban | 57,369,500 | 76.5 (75.6–77.3)** | 35,282,200 (34,708,500–35,798,600) | 61.5 (60.5–62.4)** |
| Rural | 3,227,300 | 72.6 (69.6–75.4) | 1,639,500 (1,552,300–1,729,800) | 50.8 (48.1–53.6) |
Abbreviation: CI = confidence interval.
* Women were considered to be at risk for unintended pregnancy unless they reported 1) not being sexually active with a male partner, 2) being currently pregnant or seeking pregnancy, 3) not minding being pregnant, or 4) having had had a hysterectomy.
† Women with ongoing or potential need for contraceptive services were defined as women considered to be at risk for unintended pregnancy not using permanent contraception (female sterilization or male partner vasectomy). The number of women with ongoing or potential need for contraceptive services can be used to estimate how many women might seek services.
§ 2017: Alaska, California, District of Columbia, Maine, Nevada, New Jersey, and Texas. 2019: Alabama, Arizona, Arkansas, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Louisiana, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, Virginia, West Virginia, Wisconsin, Wyoming, and Puerto Rico.
¶ Weighted numbers are rounded to the nearest 100.
** p<0.05 for chi-square test comparing the distribution of the outcome by the sociodemographic characteristic.
†† Determined using the 2013 National Center for Health Statistics urban-rural classification scheme for counties. https://www.cdc.gov/nchs/data_access/urban_rural.htm
Percentages of women aged 18–49 years who had ongoing or potential need for contraceptive services using specific contraceptive methods, by category of method or no method and jurisdiction — Behavioral Risk Factor Surveillance System, 45 jurisdictions, 2017–2019
| Jurisdiction | % of women aged 18–49 yrs (95% CI) | |||
|---|---|---|---|---|
| Long-acting reversible method | Short-acting reversible method | Barrier or other reversible method | No method | |
| Alabama | 9.6 (7.1–12.9) | 25.1 (20.7–30.1) | 37.0 (31.9–42.3) | 28.3 (23.7–33.3) |
| Alaska | 28.5 (19.6–39.5) | 18.6 (11.9–27.8) | 31.6 (21.9–43.1) | 21.3 (13.9–31.4) |
| Arizona | 13.0 (9.5–17.5) | 24.5 (19.3–30.6) | 28.3 (22.8–34.4) | 34.3 (28.5–40.5) |
| Arkansas | 9.8 (6.2–15.2) | 25.2 (19.4–32.0) | 30.1 (23.6–37.5) | 35.0 (28.6–41.9) |
| California | 15.1 (12.5–18.2) | 26.9 (23.1–31.0) | 30.4 (26.6–34.4) | 27.6 (23.9–31.6) |
| Connecticut | 16.1 (12.5–20.4) | 23.8 (19.9–28.2) | 31.1 (26.7–35.9) | 29.0 (24.8–33.6) |
| Delaware | 12.5 (8.8–17.6) | 28.1 (21.8–35.4) | 30.1 (23.6–37.6) | 29.2 (22.9–36.5) |
| District of Columbia | 11.5 (8.1–15.9) | 16.0 (12.3–20.7) | 42.6 (37.1–48.3) | 29.9 (25.2–35.0) |
| Florida | 12.9 (9.8–16.8) | 25.8 (21.2–31.0) | 28.9 (23.9–34.4) | 32.5 (27.4–38.0) |
| Georgia | 11.2 (8.2–15.0) | 25.3 (20.3–31.1) | 26.2 (21.3–31.9) | 37.3 (31.6–43.3) |
| Hawaii | 16.9 (13.6–20.7) | 21.4 (18.0–25.3) | 22.3 (18.9–26.1) | 39.4 (34.8–44.2) |
| Idaho | 29.4 (23.5–36.1) | 22.4 (17.0–28.9) | 24.0 (18.4–30.6) | 24.2 (19.1–30.2) |
| Illinois | 10.4 (8.1–13.2) | 23.8 (20.0–28.1) | 35.4 (30.9–40.2) | 30.4 (26.0–35.2) |
| Indiana | 14.0 (11.2–17.4) | 24.7 (20.8–29.2) | 29.7 (25.6–34.2) | 31.5 (27.4–35.9) |
| Iowa | 22.3 (19.3–25.7) | 28.9 (25.5–32.7) | 25.2 (22.0–28.8) | 23.5 (20.5–26.8) |
| Kansas | 19.2 (16.3–22.4) | 27.7 (24.3–31.4) | 23.7 (20.3–27.6) | 29.4 (26.0–33.1) |
| Louisiana | 11.1 (8.1–14.9) | 25.2 (20.9–30.0) | 34.3 (29.4–39.6) | 29.4 (25.2–34.0) |
| Maine | 33.6 (26.8–41.2) | 26.7 (20.6–33.8) | 19.3 (14.3–25.5) | 20.4 (15.7–26.2) |
| Maryland | 16.1 (13.5–19.1) | 24.4 (21.1–28.1) | 33.4 (29.8–37.2) | 26.1 (22.9–29.6) |
| Massachusetts | 19.5 (16.3–23.2) | 28.6 (24.5–33.0) | 31.8 (27.6–36.2) | 20.1 (16.6–24.1) |
| Minnesota | 21.9 (19.6–24.4) | 28.5 (25.8–31.3) | 23.5 (21.0–26.1) | 26.2 (23.6–28.9) |
| Mississippi | 10.3 (7.4–14.1) | 24.7 (20.1–29.9) | 34.1 (29.0–39.7) | 30.9 (26.2–36.1) |
| Missouri | 16.5 (12.8–21.1) | 27.7 (22.8–33.1) | 31.8 (26.6–37.4) | 24.1 (19.5–29.3) |
| Montana | 29.2 (24.8–34.1) | 23.2 (19.3–27.6) | 24.0 (19.9–28.6) | 23.6 (19.8–27.9) |
| Nebraska | 17.1 (13.5–21.5) | 27.0 (22.7–31.7) | 28.7 (24.5–33.4) | 27.1 (23.2–31.5) |
| Nevada | 21.2 (15.5–28.3) | 22.7 (16.9–29.8) | 23.6 (17.3–31.3) | 32.5 (25.6–40.1) |
| New Jersey | 12.6 (9.8–16.0) | 22.7 (18.6–27.4) | 31.1 (26.7–35.8) | 33.6 (29.0–38.6) |
| New Mexico | 22.5 (18.0–27.7) | 18.0 (13.8–23.1) | 27.7 (22.7–33.4) | 31.8 (26.5- 37.6) |
| New York | 14.1 (10.2–19.2) | 18.1 (14.1–22.9) | 33.7 (28.0–39.9) | 34.1 (28.4–40.2) |
| North Carolina | 20.0 (15.6–25.1) | 24.4 (19.8–29.6) | 23.7 (19.2–28.9) | 32.0 (26.8–37.6) |
| Ohio | 15.9 (11.7–21.3) | 30.8 (25.4–36.9) | 23.5 (18.8–29.0) | 29.8 (24.5–35.6) |
| Oklahoma | 16.5 (11.9–22.6) | 29.7 (23.1–37.1) | 26.7 (20.6–33.8) | 27.1 (21.4–33.7) |
| Oregon | 30.7 (26.5–35.3) | 24.2 (20.5–28.4) | 24.8 (21.1–29.0) | 20.2 (16.5–24.5) |
| Pennsylvania | 13.9 (11.0–17.3) | 30.6 (25.9–35.8) | 29.4 (24.5–34.9) | 26.1 (21.6–31.1) |
| Rhode Island | 16.6 (12.3–22.1) | 31.0 (25.3–37.4) | 26.6 (21.0–33.0) | 25.8 (20.7–31.7) |
| South Carolina | 11.9 (9.1–15.4) | 28.4 (24.0–33.3) | 30.8 (26.2–35.8) | 28.9 (24.2–34.1) |
| South Dakota | 17.6 (12.7–23.9) | 27.7 (21.2–35.2) | 26.7 (20.0–34.7) | 27.9 (21.4–35.7) |
| Tennessee | 10.5 (7.4–14.7) | 32.9 (27.3- 38.9) | 28.2 (22.6–34.6) | 28.4 (23.2–34.2) |
| Texas | 12.0 (8.6–6.5) | 18.3 (14.3–23.3) | 30.3 (24.7–36.7) | 39.3 (33.2–45.8) |
| Utah | 36.1 (33.0–39.3) | 21.9 (19.2–24.8) | 21.2 (18.7–24.0) | 20.8 (18.3–23.6) |
| Virginia | 17.4 (14.3–21.0) | 27.3 (23.1–31.9) | 25.1 (21.5–29.0) | 30.3 (26.0–34.9) |
| West Virginia | 16.6 (12.2–22.3) | 25.9 (20.4–32.2) | 27.1 (20.9–34.3) | 30.4 (24.7–36.8) |
| Wisconsin | 18.4 (13.8–24.0) | 32.4 (26.8–38.4) | 25.7 (20.5–31.6) | 23.6 (18.8–29.1) |
| Wyoming | 18.7 (13.6–25.1) | 23.3 (17.5–30.3) | 27.9 (21.6–35.3) | 30.1 (23.4–37.8) |
| Puerto Rico | 6.9 (4.7–10.0) | 13.7 (10.8–17.4) | 33.5 (29.1–38.2) | 45.8 (41.1–50.7) |
|
|
|
|
|
|
Abbreviation: CI = confidence interval.
* Women with ongoing or potential need for contraceptive services were defined as women considered to be at risk for unintended pregnancy not using permanent contraception (female sterilization or male partner vasectomy). The number of women with ongoing or potential need for contraceptive services can be used to estimate how many women might seek services.
† Categories of contraceptive methods reflect different levels of effort for method initiation and continuation. Long-acting reversible contraception methods include intrauterine devices and contraceptive implants; these methods require the most clinical effort for initiation but require minimal follow-up until time for removal or reinsertion and minimal action by the woman. Short-acting reversible contraception methods include injectables, pills, transdermal patches, and vaginal rings; these methods require less clinical effort for initiation than long-acting reversible methods but require ongoing clinical services and supplies and action by the woman to maintain use. Barrier or other reversible contraception methods included diaphragms, condoms (male or female), withdrawal, cervical caps, sponges, spermicides, fertility-awareness–based methods, and emergency contraception; these methods have little or no need for clinical services for initiation, but require action by the woman or her partner to maintain use.
§ Data shown are from 2019, except 2017 data are shown for seven jurisdictions: Alaska, California, District of Columbia, Maine, Nevada, New Jersey, and Texas.